Endocyte, Inc. (NASDAQ:ECYT) Reported Basic Consolidated EPS Of $-0.984 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for Endocyte, Inc. (NASDAQ:ECYT) for the period ended 2015-12-31 was $-0.984. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $-0.984.

EPS from continuing operations

Coming to basic EPS from continuing operations, Endocyte, Inc. (NASDAQ:ECYT) reported $-0.984 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $-0.984.

EPS contribution from parent

For the annual period ended 2015-12-31, Endocyte, Inc. (NASDAQ:ECYT) received basic EPS of $-0.984 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $-0.984.

Basic net EPS

For the annual period ended 2015-12-31, Endocyte, Inc. (NASDAQ:ECYT) reported basic net EPS of $-0.98. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $-0.98.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $-0.984. For the quarter ended 2015-12-31, consolidated diluted EPS was $-0.984.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-0.984 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $-0.984.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $-0.98. For the quarterly period ended 2015-12-31, net diluted EPS was $-0.98.

Diluted EPS from parent

From the parent company, Endocyte, Inc. (NASDAQ:ECYT) received diluted EPS of $-0.984 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $-0.984.

Endocyte, Inc. (NASDAQ:ECYT) posted net basic EPS reading of $-0.98 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $-0.98 was for the quarter ended 2015-12-31.

Net diluted EPS for Endocyte, Inc. (NASDAQ:ECYT) for the annual period ended 2015-12-31 was $-0.98. The company also reported net diluted EPS reading of $-0.98 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 41.94 while for the quarter ended 2015-12-31 is 41.94.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 41.94 while for the quarter ended 2015-12-31 is 41.94.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 30 times, 1 visits today)